As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

 5/17/21  Acelrx Pharmaceuticals Inc.       10-Q        3/31/21   62:4.9M                                   RDG Filings/FA           
 3/31/21  Bozilenko Marina                  4          Director²   1:6K   Acelrx Pharmaceuticals Inc.       DONNELLEY FIN… File16/FA 
 3/31/21  Bozilenko Marina                  3          Director²   2:6K   Acelrx Pharmaceuticals Inc.       DONNELLEY FIN… File16/FA 
 3/31/21  Acelrx Pharmaceuticals Inc.       8-K:5,9     3/30/21   12:184K                                   RDG Filings/FA           

____________
¹	Filing/Form Types:
	3	Initial Statement of Beneficial Ownership of Securities by an Insider — Form 3 { The Filer is an Insider² of the Issuer }.
	4	Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 { The Filer is an Insider² of the Issuer }.
	8-K	Current Report — Form 8-K { Item 1: Business & Operations;  2: Financial Info;  3: Securities & Trading;  4: Accountants & Accounting;  5: Governance & Management;  6: Asset-Backed Securities;  7: Disclosures;  8: Events;  9: Financials }.
	10-Q	Quarterly Report — Form 10-Q.
²	Insider:  The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer.